Closed Drug Transfer Systems Market Report – Research, Industry Analysis Reports and Market Demands

Global Closed Drug Transfer Systems Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Closed Drug Transfer Systems Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Closed Vial Access Devices
- 1.3.3 Closed Syringe Safety Devices
- 1.3.4 Closed Bag/Line Access Devices
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Closed Drug Transfer Systems Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Clinic
1.5 Global Closed Drug Transfer Systems Market Size & Forecast
- 1.5.1 Global Closed Drug Transfer Systems Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Closed Drug Transfer Systems Sales Quantity (2021-2032)
- 1.5.3 Global Closed Drug Transfer Systems Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Closed Drug Transfer Systems by Manufacturer

3.1 Global Closed Drug Transfer Systems Sales Quantity by Manufacturer (2021-2026)
3.2 Global Closed Drug Transfer Systems Revenue by Manufacturer (2021-2026)
3.3 Global Closed Drug Transfer Systems Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Closed Drug Transfer Systems by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Closed Drug Transfer Systems Manufacturer Market Share in 2025
- 3.4.3 Top 6 Closed Drug Transfer Systems Manufacturer Market Share in 2025
3.5 Closed Drug Transfer Systems Market: Overall Company Footprint Analysis
- 3.5.1 Closed Drug Transfer Systems Market: Region Footprint
- 3.5.2 Closed Drug Transfer Systems Market: Company Product Type Footprint
- 3.5.3 Closed Drug Transfer Systems Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Closed Drug Transfer Systems Market Size by Region
- 4.1.1 Global Closed Drug Transfer Systems Sales Quantity by Region (2021-2032)
- 4.1.2 Global Closed Drug Transfer Systems Consumption Value by Region (2021-2032)
- 4.1.3 Global Closed Drug Transfer Systems Average Price by Region (2021-2032)
4.2 North America Closed Drug Transfer Systems Consumption Value (2021-2032)
4.3 Europe Closed Drug Transfer Systems Consumption Value (2021-2032)
4.4 Asia-Pacific Closed Drug Transfer Systems Consumption Value (2021-2032)
4.5 South America Closed Drug Transfer Systems Consumption Value (2021-2032)
4.6 Middle East & Africa Closed Drug Transfer Systems Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Closed Drug Transfer Systems Sales Quantity by Type (2021-2032)
5.2 Global Closed Drug Transfer Systems Consumption Value by Type (2021-2032)
5.3 Global Closed Drug Transfer Systems Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Closed Drug Transfer Systems Sales Quantity by Application (2021-2032)
6.2 Global Closed Drug Transfer Systems Consumption Value by Application (2021-2032)
6.3 Global Closed Drug Transfer Systems Average Price by Application (2021-2032)

7 North America

7.1 North America Closed Drug Transfer Systems Sales Quantity by Type (2021-2032)
7.2 North America Closed Drug Transfer Systems Sales Quantity by Application (2021-2032)
7.3 North America Closed Drug Transfer Systems Market Size by Country
- 7.3.1 North America Closed Drug Transfer Systems Sales Quantity by Country (2021-2032)
- 7.3.2 North America Closed Drug Transfer Systems Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Closed Drug Transfer Systems Sales Quantity by Type (2021-2032)
8.2 Europe Closed Drug Transfer Systems Sales Quantity by Application (2021-2032)
8.3 Europe Closed Drug Transfer Systems Market Size by Country
- 8.3.1 Europe Closed Drug Transfer Systems Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Closed Drug Transfer Systems Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Closed Drug Transfer Systems Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Closed Drug Transfer Systems Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Closed Drug Transfer Systems Market Size by Region
- 9.3.1 Asia-Pacific Closed Drug Transfer Systems Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Closed Drug Transfer Systems Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Closed Drug Transfer Systems Sales Quantity by Type (2021-2032)
10.2 South America Closed Drug Transfer Systems Sales Quantity by Application (2021-2032)
10.3 South America Closed Drug Transfer Systems Market Size by Country
- 10.3.1 South America Closed Drug Transfer Systems Sales Quantity by Country (2021-2032)
- 10.3.2 South America Closed Drug Transfer Systems Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Closed Drug Transfer Systems Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Closed Drug Transfer Systems Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Closed Drug Transfer Systems Market Size by Country
- 11.3.1 Middle East & Africa Closed Drug Transfer Systems Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Closed Drug Transfer Systems Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Closed Drug Transfer Systems Market Drivers
12.2 Closed Drug Transfer Systems Market Restraints
12.3 Closed Drug Transfer Systems Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Closed Drug Transfer Systems and Key Manufacturers
13.2 Manufacturing Costs Percentage of Closed Drug Transfer Systems
13.3 Closed Drug Transfer Systems Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Closed Drug Transfer Systems Typical Distributors
14.3 Closed Drug Transfer Systems Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Closed Drug Transfer Systems market size was valued at US$ 1168 million in 2025 and is forecast to a readjusted size of US$ 3608 million by 2032 with a CAGR of 17.7% during review period.
Closed Drug Transfer Systems is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
North America is the largest Closed Drug Transfer Systems market with about 73% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are BD Medical, Inc, Equashield, LLC, ICU Medical, Inc, Teva Medical Ltd, Corvida Medical etc. Top 3 companies occupied about 74% market share.
The rapid development of the closed-system drug transfer device market is driven by several key factors. First, there is a growing global emphasis on medical safety and sterile operations, particularly in hospitals, clinics, and other healthcare facilities. Preventing drug contamination and cross-infection has become a top priority. Closed-system drug transfer devices effectively ensure sterility during the transportation and transfer of drugs, reducing the risk of exposure to harmful substances for both healthcare workers and patients.
Second, advancements in biopharmaceuticals and personalized medicine have led to an increase in new types of drugs (such as cancer drugs and immunotherapy agents) that require highly controlled storage and transport conditions. These drugs are often highly active and sensitive, necessitating handling in controlled environments to ensure their stability and efficacy. Additionally, increasingly stringent regulations are compelling healthcare institutions to adopt more advanced transfer systems to comply with standards and guidelines, thereby avoiding potential legal risks and penalties.
In the future, the closed-system drug transfer device market will exhibit several significant trends. On one hand, technological innovation will continue to propel this field forward. For instance, the application of intelligent and automated technologies will make transfer devices more efficient, precise, and easier to manage, reducing the likelihood of human error. The integration of Internet of Things (IoT) technology allows these devices to monitor the status and environmental parameters of drugs in real-time, providing immediate feedback and alerts, which enhances supply chain transparency and traceability.
On the other hand, influenced by concepts of environmental protection and sustainability, manufacturers will place greater emphasis on the environmental performance and energy efficiency of their products. They will develop materials and technologies that are lighter, more energy-efficient, and easier to recycle. Furthermore, as the uneven distribution of global healthcare resources becomes more pronounced, the growing demand for telemedicine services will drive the use of closed-system drug transfer devices in remote areas and primary healthcare facilities, further expanding market coverage.
This report is a detailed and comprehensive analysis for global Closed Drug Transfer Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Closed Drug Transfer Systems market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Closed Drug Transfer Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Closed Drug Transfer Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Closed Drug Transfer Systems market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Closed Drug Transfer Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Closed Drug Transfer Systems market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD Medical, Inc, Equashield, ICU Medical, Simplivia Healthcare Ltd., Corvida Medical, B. Braun, Yukon Medical, JMS, Caragen Ltd., Epic Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Closed Drug Transfer Systems market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Closed Vial Access Devices
Closed Syringe Safety Devices
Closed Bag/Line Access Devices
Market segment by Application
Hospital
Clinic
Major players covered
BD Medical, Inc
Equashield
ICU Medical
Simplivia Healthcare Ltd.
Corvida Medical
B. Braun
Yukon Medical
JMS
Caragen Ltd.
Epic Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Closed Drug Transfer Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Closed Drug Transfer Systems, with price, sales quantity, revenue, and global market share of Closed Drug Transfer Systems from 2021 to 2026.
Chapter 3, the Closed Drug Transfer Systems competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Closed Drug Transfer Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Closed Drug Transfer Systems market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Closed Drug Transfer Systems.
Chapter 14 and 15, to describe Closed Drug Transfer Systems sales channel, distributors, customers, research findings and conclusion.

Buy now